Sunny Hostin's Weight Loss Has Totally Changed Her Face

"The View" co-host Sunny Hostin has undergone a body transformation for the books. The talk show host revealed she lost 40 pounds that was gained during the COVID-19 pandemic, and even though it has totally changed her face, appears to have no regrets. Hostin's post weight loss look hasn't worsened her appearance by any means but has somewhat made her appear older, as seen in side-by-side photos. As expected with losing a significant amount of fat in the face, it has created more visible wrinkles under and around her eyes and mouth, accentuated her smile lines, and slightly narrowed the shape of her face.

John Nacion & Lars Niki/Getty

For Hostin, being on the heavier side didn't sit well with her, so she felt compelled to shed the weight quickly before going back on live television — ultimately pushing her towards drastic measures. Opting for a fast-acting solution, the former prosecutor turned to the Type 2 diabetes medication, Mounjaro. "There is shame when you've gained weight," she admitted during a 2024 episode of "The View" (via People). "I had never experienced that kind of shame before. During COVID, I gained 40 pounds," she said. "All I did was eat ... I love to cook, and I found out, I love to eat. And I was horrified about the fact that I would have to come out on air. So, I also took Mounjaro."

Fortunately for the television host, she hasn't experienced any of the unattractive side-effects often associated with Mounjaro and other GLP-1 drugs like Ozempic, which produces sagging skin, a drooping neck, and hollowed or sunken facial features due to rapid weight loss — as commonly seen with other celebrities who have fallen victim to "Ozempic Face."

Mounjaro (generic name: tirzepatide), which activates two gut hormone receptors — glucagon-like peptide-1 receptor (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP) — to manage blood sugar, has been shown in a systematic review via PLOS ONE, to produce more potent weight loss compared to single-action drugs like Ozempic. Additionally, research published in "The Pharmaceutical Journal" suggests the drug may lead to recurring weight gain, though can be managed with proper diet and exercise.

Hostin doesn't seem a bit concerned about potentially regaining the weight, nor has she experienced other side effects such as appetite changes or persistent cravings since coming off the drug. "I feel really great," she told the Daily Mail in an exclusive interview. "I don't know what everyone else's experience with it is, but I never gained any weight back." She added that she was never a "big eater" to begin with and maintained consistency with her fitness routine, noting she "never stopped working out."

Despite a range of commonly reported side effects, including nausea, constipation, abdominal pain, diarrhea, and in some cases, allergic reactions such as swelling of the face, lips, tongue, or throat — Hostin appears to be one of the lucky ones, getting through the experience unscathed. "Yeah, I'm just living life and feeling pretty good," she said. Also, admitting she'd be open to going back on Mounjaro in the future, "If I needed to, sure. Why not?" However, unlike many celebs, who have bared all about their bad experiences with Ozempic and other GLP-1s, Hostin acknowledges that things could still go south for her. "Hopefully, nothing bad will happen to me," she added.